November 25, 2020

The Niche

Knoepfler lab stem cell blog

Intellicell

4 min read

What’s the deal with IntelliCell Biosciences, headed up by Dr. Steven Victor? Sometimes science can move at warp speed and that is even more true of the stem cell field. One stem cell establishment that seems to be in a particularly intense period of activity and that has drawn a great deal of attention lately is IntelliCell Biosciences, headed up by Victor. The company’s financial state and its interactions with the FDA have drawn particularly intense attention and scrutiny of late. Below is my …Read More

1 min read

In the past week I’ve been getting an unprecedented number of emails, blog comments, and even phone calls about IntelliCell Biosciences of NY (stock symbol SVFC). It’s quite remarkable and I’ve had to moderate many comments related to IntelliCell for content not following this blog’s comment rules. The grapevine is smoking hot on this company. It’s been a big week of buzz for the company including uncertainty for example related to an apparent foreclosure sale for tomorrow (now possibly canceled) and lawsuits. What I hear …Read More

3 min read

IntelliCell BioSciences, Inc. of New York, a clinical stem cell establishment, has had a rough time of it lately. For example, a recent piece of bad news is that there is an impending foreclosure sale of the company’s assets. What exactly that means for the company more broadly remains unknown, but a few people tell me (take this with a grain of salt either way) that the company is still seeing patients. IntelliCell also has run into issues on multiple occasions including in 2012 with the FDA …Read More

1 min read

IntelliCell BioSciences has had a terrible year. Well, there’s terrible and then there’s terrible! Things seem to be getting worse. For background, I detailed its troubles, ups, and downs here in a previous post. I was just working on a new draft post on the most recent, concerning FDA 483 report on the company, which I will release soon (it was released to me by the FDA last week) in a new post coming up, when I heard the news that reportedly the company is …Read More